Ravi Narayan Venkatachalam, a U.S.-based biotechnologist at Jeneil Biotech, specializes in fermentation and specialty ...

Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

US biotech Syndeio Biosciences has launched with over $90 million in funding and a pipeline of synapse-targeting ...

The race to develop transcatheter systems for tricuspid regurgitation (TR) continues, and early-stage report cards are in for ...

What if success—and the culture that rewards it—pushes your body past its breaking point? Discover why panic may be our ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...

Scientists at the Terasaki Institute for Biomedical Innovation (TIBI), led by Dr. Vadim Jucaud (Assistant Professor), have ...

However, just like NIDHI, BIG’s once-impressive grant amount of up to Rs 50 lakh for 18 months — the only grant at the time ...

Wilson's new company, Philadelphia-based Gemma Biotherapeutics, plans to start testing gene therapies in Brazil this year.

MIT today launched its Initiative for New Manufacturing (INM), an Institute-wide effort to reinfuse U.S. industrial ...